CBUS
Cibus Global LLC
NASDAQ: CBUS · HEALTHCARE · BIOTECHNOLOGY
$1.40
+9.37% today
Updated 2026-04-30
Market cap
$114.42M
P/E ratio
—
P/S ratio
31.44x
EPS (TTM)
$-2.78
Dividend yield
—
52W range
$1 – $4
Volume
0.7M
Cibus Global LLC (CBUS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6.69M | $-9.24M | $-12.79M | $-20.25M | $-31.95M | $-43.67M | $-18.81M | $-19.36M | $-46.21M | $-58.04M | $-50.59M |
| Capital expenditures | $665000.00 | $10.42M | $779000.00 | $1.85M | $2.97M | $1.79M | $497000.00 | $1.52M | $4.32M | $808000.00 | $578000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $692000.00 | $948000.00 | $12.09M | $4.38M | $9.18M | $4.97M | $2.09M | $4.00M | $16.09M | $10.75M | $8.19M |
| Free cash flow | $-7.36M | $-19.66M | $-13.56M | $-22.10M | $-34.92M | $-45.46M | $-19.31M | $-20.88M | $-50.53M | $-58.85M | $-51.17M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $110000.00 | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — |